These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 17018594)
1. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594 [TBL] [Abstract][Full Text] [Related]
2. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610 [TBL] [Abstract][Full Text] [Related]
3. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520 [TBL] [Abstract][Full Text] [Related]
4. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394 [TBL] [Abstract][Full Text] [Related]
5. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003 [TBL] [Abstract][Full Text] [Related]
6. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383 [TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377 [TBL] [Abstract][Full Text] [Related]
9. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H; Geeraerts H; Verbeken E; Nuyts S Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417 [TBL] [Abstract][Full Text] [Related]
12. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459 [TBL] [Abstract][Full Text] [Related]
13. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670 [TBL] [Abstract][Full Text] [Related]
15. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533 [TBL] [Abstract][Full Text] [Related]
16. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck. Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737 [TBL] [Abstract][Full Text] [Related]
17. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Dallol A; Morton D; Maher ER; Latif F Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722 [TBL] [Abstract][Full Text] [Related]
18. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells. Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961 [TBL] [Abstract][Full Text] [Related]
20. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]